Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LISOCABTAGENE MARALEUCEL vs LOFEXIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LISOCABTAGENE MARALEUCEL vs LOFEXIDINE: Safety Overview

Metric LISOCABTAGENE MARALEUCEL LOFEXIDINE
Total FAERS Reports 738 139
Deaths Reported 132 0
Death Rate 17.9% N/A
Hospitalizations 396 17
Average Patient Age 66.3 yrs 47.5 yrs
% Female Patients 36.8% 51.8%
FDA Approval Date N/A Aug 20, 2024
Manufacturer Juno Therapeutics, Inc. Prasco Laboratories
Route N/A ORAL
Marketing Status N/A Prescription